Quick Answer
Eton Pharmaceuticals, Inc. reported Stockholders Equity of $26.15 million for fiscal year 2025.
Eton Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $26.15M | +7.1% |
| 2024 | $24.43M | +57.8% |
| 2023 | $15.48M | +18.3% |
| 2022 | $13.08M | -25.8% |
| 2021 | $17.63M | +0.0% |
| 2020 | $17.63M | +67.1% |
| 2019 | $10.55M | -59.9% |
| 2018 | $26.30M | +482.6% |
| 2017 | -$6.87M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $23.13M | +44.7% | -3.5% |
| June 30, 2025 | $23.96M | +78.0% | -2.0% |
| March 31, 2025 | $24.45M | +57.8% | +0.1% |
| December 31, 2024 | $24.43M | +57.8% | +52.9% |
| September 30, 2024 | $15.98M | -5.4% | +18.7% |
| June 30, 2024 | $13.46M | -19.5% | -13.1% |
| March 31, 2024 | $15.49M | +37.8% | +0.1% |
| December 31, 2023 | $15.48M | +18.3% | -8.4% |
- Eton Pharmaceuticals, Inc. showed an increase of +7.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2017–2025 period, Eton Pharmaceuticals, Inc.’s stockholders equity has grown by 480.5% (from -$6.87 million to $26.15 million).
- The most recent figure is from Eton Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: